Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response.

Law HC, Lagundžin D, Clement EJ, Qiao F, Wagner ZS, Krieger KL, Costanzo-Garvey D, Caffrey TC, Grem JL, DiMaio DJ, Grandgenett PM, Cook LM, Fisher KW, Yu F, Hollingsworth MA, Woods NT.

Clin Cancer Res. 2020 Mar 1;26(5):1065-1076. doi: 10.1158/1078-0432.CCR-19-1496. Epub 2019 Dec 17.

2.

Delineating the role of FANCA in glucose-stimulated insulin secretion in β cells through its protein interactome.

Lagundžin D, Hu WF, Law HCH, Krieger KL, Qiao F, Clement EJ, Drincic AT, Nedić O, Naldrett MJ, Alvarez S, Woods NT.

PLoS One. 2019 Aug 28;14(8):e0220568. doi: 10.1371/journal.pone.0220568. eCollection 2019.

3.

Proximity Labeling To Map Host-Pathogen Interactions at the Membrane of a Bacterium-Containing Vacuole in Chlamydia trachomatis-Infected Human Cells.

Olson MG, Widner RE, Jorgenson LM, Lawrence A, Lagundzin D, Woods NT, Ouellette SP, Rucks EA.

Infect Immun. 2019 Oct 18;87(11). pii: e00537-19. doi: 10.1128/IAI.00537-19. Print 2019 Nov.

4.

Identification of Potential Cerebrospinal Fluid Biomarkers To Discriminate between Infection and Sterile Inflammation in a Rat Model of Staphylococcus epidermidis Catheter Infection.

Skar GL, Beaver M, Aldrich A, Lagundzin D, Thapa I, Woods N, Ali H, Snowden J, Kielian T.

Infect Immun. 2019 Aug 21;87(9). pii: e00311-19. doi: 10.1128/IAI.00311-19. Print 2019 Sep.

5.

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

Hu WF, Krieger KL, Lagundžin D, Li X, Cheung RS, Taniguchi T, Johnson KR, Bessho T, Monteiro ANA, Woods NT.

Cell Death Discov. 2019 Jun 19;5:105. doi: 10.1038/s41420-019-0185-3. eCollection 2019.

6.

Alteration of IGFBP-1 in soccer players due to intensive training.

Lagundžin D, Vucić V, Glibetić M, Nedić O.

Int J Sport Nutr Exerc Metab. 2013 Oct;23(5):449-57. Epub 2013 Mar 26.

PMID:
23535908
7.

Posttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with type 2 diabetes mellitus assessed by affinity chromatography.

Nedić O, Lagundžin D, Masnikosa R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Sep 1;904:93-8. doi: 10.1016/j.jchromb.2012.07.028. Epub 2012 Jul 31.

PMID:
22884472
8.

Association between the pattern of IGFBP-1 alteration and the glucose/insulin metabolic control.

Nedić O, Masnikosa R, Lagundžin D.

Exp Clin Endocrinol Diabetes. 2011 May;119(5):306-13. doi: 10.1055/s-0030-1267963. Epub 2010 Nov 22.

PMID:
21104586
9.

Alterations of insulin-like growth factor binding protein 3 (IGFBP-3) glycosylation in patients with breast tumours.

Baricević I, Masnikosa R, Lagundzin D, Golubović V, Nedić O.

Clin Biochem. 2010 Jun;43(9):725-31. doi: 10.1016/j.clinbiochem.2010.03.006. Epub 2010 Mar 19.

PMID:
20307522
10.

Characterisation of N-glycans bound to IGFBP-3 in sera from healthy adults.

Masnikosa R, Baricević I, Lagundzin D, Nedić O.

Biochimie. 2010 Jan;92(1):97-101. doi: 10.1016/j.biochi.2009.09.015. Epub 2009 Oct 1.

PMID:
19800385

Supplemental Content

Loading ...
Support Center